Clinical trials recruiting for Multiple Sclerosis, Relapsing-Remitting

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy
  NCT05359653 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location
• Clinnova-MS: A Prospective Cohort Study of Patients With Multiple Sclerosis (Switzerland)
  NCT06526364 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS
  NCT06390930 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Fatigue Alleviation Through Neuromodulating Therapy in Multiple Sclerosis
  NCT06569550 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
  NCT05964829 · Phase: Not applicable (e.g. observational or device study) · Ages: 22 Years to 75 Years · Sex: All (male and female) · 1 location
• Intermittent Hypoxia in Persons With Multiple Sclerosis
  NCT06276634 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Investigating the Effect of Ocrelizumab in African Americans and Caucasians With Relapsing Multiple Sclerosis
  NCT04458688 · Phase: Not specified · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
• Light Stimulation to Improve Visual Function After Optic Neuritis in Persons with Multiple Sclerosis
  NCT06389968 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
• MS-ResearchBiomarkerS
  NCT05204459 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Motor Learning of Fall Resistant Skills Through Slip and Trip Exposure in Multiple Sclerosis
  NCT06919900 · Phase: Not applicable (e.g. observational or device study) · Ages: 45 Years to 89 Years · Sex: All (male and female) · 1 location
• Multiple Sclerosis Treatment With Autologous Hematopoietic Stem Cell Transplantation in the Netherlands
  NCT06567197 · Phase: Not specified · Ages: 18 Years to 65 Years · Sex: All (male and female) · 2 locations
• Multiple Sclerosis and the Effects of Ketogenic Diet Therapy
  NCT06715436 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
• Non-inferiority Study of Rituximab Compared to Ocrelizumab in Relapsing MS
  NCT05834855 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Retinal Neuro-vascular Coupling in Patients With Multiple Sclerosis
  NCT03401879 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
  NCT06408259 · Phase: Phase 3 · Ages: 10 Years to 17 Years · Sex: All (male and female) · 33 locations
• TOTEM RRMS : TestOsterone TreatmEnt on Neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis
  NCT03910738 · Phase: Phase 2 · Ages: 18 Years to 55 Years · Sex: Male · 5 locations
• Treatment of Cognitive Deficits in Multiple Sclerosis With High-Definition Transcranial Direct Current Stimulation
  NCT05958381 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location

Related conditions

Trials recruiting for Multiple Sclerosis, Relapsing-Remitting often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Multiple Sclerosis, Relapsing-Remitting trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.